Indeed, treatment with ryanodine receptor (RyR) blocker dantrolene was shown to reduce Aβ burden, increase PSD-95 expression and improve learning and memory in a APPsw-expressing mouse model of AD [42]. This evidence concerns the gene DLG4 and Alzheimer disease.